StonvexLoading…
StonvexStonvexStonvexCore line items from LFUS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.39B | $2.19B | $2.36B | $2.51B |
Operating Income | $37.53M | $158.78M | $360.86M | $500.83M |
Net Income | $-71.70M | $100.19M | $259.49M | $373.31M |
EPS (Diluted) | $-2.89 | $4.00 | $10.34 | $14.94 |
Total Assets | $3.96B | $3.89B | $4.00B | $3.90B |
Total Liabilities | $1.53B | $1.48B | $1.51B | $1.69B |
Cash & Equivalents | $563.39M | $724.92M | $555.51M | $562.59M |
Free Cash Flow OCF − CapEx | $366.13M | $291.74M | $371.20M | $315.38M |
Shares Outstanding | 24.82M | 25.04M | 25.10M | 24.99M |